On Purpose with Jay Shetty
Also in Health & Fitness
Health & Fitness
VJHemOnc Podcast
by VJHemOnc
Today: #172 in Health & Fitness, India on our combined chart.
Share this ranking
Claiming needs an RSS feed. Contact us.
Chart positions today · Australia
Not on the United States charts we track today.
Not on the United Kingdom charts we track today.
Not on the Canada charts we track today.
Not on the Australia charts we track today.
Not on the Germany charts we track today.
Not on the Brazil charts we track today.
Not on the Mexico charts we track today.
Not on the New Zealand charts we track today.
Not on the Ireland charts we track today.
Not on the Japan charts we track today.
Not on the Philippines charts we track today.
Not on the South Africa charts we track today.
If you like VJHemOnc Podcast, try…
The Checkup with Doctor Mike
Also in Health & Fitness
Katie Austin Workouts
Also in Health & Fitness
CME in Minutes: Education in Oncology & Hematology
Similar topics: hematology and oncology
Two Onc Docs
Also in Health & Fitness
Simply Oncology
Also in Health & Fitness
Ranking history · Australia
No ranking history for this show in Australia over the last 7 days.
Latest episodes
-
IMS 2026 highlights: advances in multiple myeloma treatment and the path towards cure
October 9, 2026 · 25 minIn this episode of the VJHemOnc podcast, experts discuss key advances in multiple myeloma presented at the 23rd Annual Meeting and Exposition of the International Myeloma Society (IMS 2026) in Glasgow, UK. Pieter Sonneveld, MD, PhD…
-
Personalizing BTK Inhibitor Therapy in CLL: from treatment selection to long-term management
October 2, 2026 · 22 minThis VJHemOnc podcast explores how BTK inhibitor therapy can be personalized for patients with chronic lymphocytic leukemia (CLL), considering disease biology, patient characteristics and treatment goals. Kerry Rogers, MD, The Ohio State…
-
Using BTK inhibitors in lymphoma: practical considerations for community physicians
September 11, 2026 · 23 minThis episode of the VJHemOnc podcast, featuring Manali Kamdar, MD, University of Colorado Cancer Center, Denver, CO, focuses on the practical use of BTK inhibitors (BTKis) in non-Hodgkin lymphoma (NHL). Dr Kamdar begins by discussing which…
-
AAV gene therapy in hemophilia: progress, challenges and what comes next
September 3, 2026 · 24 minThis VJHemOnc podcast explores the evolving role of gene therapy in hemophilia, focusing on the challenges of AAV-based approaches and the development of next-generation strategies. Radek Kaczmarek, PhD, Indiana University School of…
-
Clinical considerations in MCL management: frailty assessment, the multidisciplinary team & managing the use of BTKis
August 26, 2026 · 18 minThis VJHemOnc podcast explores the evolving management of mantle cell lymphoma (MCL), from assessing patient fitness to sequencing therapy after BTK inhibitor progression. Tycel Phillips, MD, FASCO, City of Hope, Duarte, CA, and Yasmin…
Show 7 more episodesShow fewer episodes
-
Sequencing therapies in multiple myeloma: navigating an expanding treatment landscape
August 24, 2026 · 24 minThis VJHemOnc podcast explores the evolving treatment landscape in multiple myeloma, focusing on treatment selection and sequencing across the disease course. Fredrik Schjesvold, MD, PhD, Oslo University Hospital, Oslo, Norway, discusses…
-
The evolving treatment landscape in ALL: the growing role of immunotherapy and reduced reliance on chemotherapy
August 14, 2026 · 24 minThere has been a significant shift in the treatment of acute lymphoblastic leukemia (ALL), driven by the emergence of novel immunotherapies. In this episode, leading experts explore how these advances are changing the treatment landscape…
-
Precision medicine in MDS: tailoring treatment through molecular profiling
August 7, 2026 · 20 minThis VJHemOnc podcast explores how precision medicine is reshaping the management of myelodysplastic syndromes (MDS). Alex Bataller, MD, PhD, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses whole genome…
-
The current and future role of BTK inhibitors across non-Hodgkin lymphoma subtypes
July 23, 2026 · 24 minThis episode of the VJHemOnc podcast explores the current and future role of BTK inhibition across several non-Hodgkin lymphoma (NHL) subtypes. First, Charalampia Kyriakou, MD, PhD, University College London Hospitals NHS Trust (UCLH)…
-
The diagnosis and management of hematologic malignancies during pregnancy
July 16, 2026 · 18 minIn this episode of the VJHemOnc podcast, Daan Dierickx, MD, PhD, KU Leuven and University Hospitals Leuven, Leuven, Belgium, shares insight into the diagnosis and management of hematologic malignancies during pregnancy. Dr Dierickx…
-
Hodgkin lymphoma in 2026: frontline strategies, ctDNA, and treatment after relapse
July 10, 2026 · 19 minThis VJHemOnc podcast explores the latest advances in Hodgkin lymphoma, from evolving frontline treatment strategies to emerging approaches in relapsed and refractory disease. Graham Collins, MA, MBBS, MRCP, FRCPath, DPhil, Oxford…
-
Sequencing BTK inhibitor therapy in CLL: treatment considerations and emerging strategies
June 30, 2026 · 20 minThis podcast explores sequencing strategies and treatment considerations for BTK inhibitors in chronic lymphocytic leukemia (CLL). Jennifer Brown, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, discusses treatment options following…
About the show
The Video Journal of Hematology and Hematological Oncology (VJHemOnc) podcast covers the latest hematological oncology and hematology news from international experts – from leukemias, lymphomas, MDS and MPNs, to sickle cell, aplastic anemia and rare diseases. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion. If you enjoy the podcast, please leave us a rating and review! For more news visit www.vjhemonc.com